Dermatology focuses on the health of the skin, hair, and nails. Learn about the diagnosis and treatment of acne, eczema, skin cancer, and cosmetic procedures.
Send us all your questions or requests, and our expert team will assist you.
Understanding the symptoms and conditions associated with basal cell carcinoma (BCC) is essential for early detection and successful treatment. This page is designed for international patients and caregivers seeking clear, medically accurate information about BCC, a common form of skin cancer. According to the World Health Organization, skin cancers represent the most frequently diagnosed cancers worldwide, with BCC accounting for nearly 80% of cases. Early recognition of the visual cues and underlying risk factors can dramatically improve outcomes.
In the following sections, you will find detailed explanations of typical clinical signs, contributing health conditions, diagnostic pathways, and the range of therapeutic options available at Liv Hospital. The information is tailored to help patients make informed decisions while navigating the international healthcare journey.
Basal cell carcinoma originates from the basal cells located in the deepest layer of the epidermis. Although it rarely spreads to distant organs, BCC can cause significant local tissue damage if left untreated. The tumor typically appears on sun‑exposed areas such as the face, neck, and hands, but it may develop elsewhere.
Studies show that individuals with fair skin, a history of intense ultraviolet (UV) exposure, and advancing age are at higher risk. Men are slightly more affected than women, though the gap narrows in regions with strong sun‑protection campaigns.
Even though BCC is not typically life‑threatening, its location on visible areas can lead to psychological distress, prompting many patients to seek timely, aesthetic‑preserving treatments.
Recognizing the symptoms early can facilitate prompt medical attention. Below is a comprehensive list of the most frequently reported clinical signs.
Patients often notice a change in skin texture or color, especially after prolonged sun exposure. If any of these signs persist, a dermatologist should evaluate the lesion promptly.
Various conditions can increase susceptibility to BCC. Understanding these risk factors helps in both prevention and early detection.
In addition, certain medical conditions like chronic inflammatory skin diseases may create an environment conducive to malignant transformation. Patients with these backgrounds should schedule regular skin examinations, especially when traveling abroad for care.
Accurate diagnosis of BCC relies on a combination of visual inspection, dermoscopic assessment, and histopathological confirmation. The following table outlines the typical steps performed at Liv Hospital.
Liv Hospital’s multidisciplinary team ensures that each step is coordinated, minimizing wait times for international patients while maintaining JCI‑accredited standards of care.
Therapeutic strategies for BCC range from minimally invasive procedures to advanced surgical techniques. The choice depends on lesion size, location, histologic subtype, and patient preferences.
Liv Hospital integrates state‑of‑the‑art technologies such as robotic‑assisted surgery and laser ablation, ensuring that international patients receive personalized, evidence‑based care.
After successful removal of basal cell carcinoma, diligent follow‑up is essential to detect recurrences early and to manage any treatment‑related side effects.
High‑resolution dermoscopy and digital photography are employed to document the treated area and to compare with future examinations. For patients with extensive disease history, a full‑body skin check is incorporated into routine health assessments.
Liv Hospital’s international patient coordination team assists with scheduling virtual follow‑up appointments, ensuring continuity of care even after patients return to their home countries.
While some risk factors such as genetics cannot be altered, many lifestyle modifications can reduce the likelihood of developing new BCC lesions.
Adopting these measures not only lowers the risk of basal cell carcinoma but also contributes to overall skin health, an important consideration for patients traveling for medical care.
Liv Hospital offers JCI‑accredited, internationally recognized expertise in dermatologic oncology, including basal cell carcinoma management. Our multidisciplinary team combines cutting‑edge technology with compassionate, 360‑degree patient support—covering appointments, interpreter services, transportation, and accommodation assistance. International patients benefit from seamless coordination, ensuring that high‑quality care is delivered efficiently and comfortably.
Ready to schedule a consultation with our skin‑cancer specialists? Contact Liv Hospital today to arrange a personalized evaluation and discover how our comprehensive services can support your journey toward optimal health.
Liv Hospital Ulus
Asst. Prof. MD. Ayşe Deniz Akkaya
Dermatology
Liv Hospital Ulus
Asst. Prof. MD. Nazlı Caf
Dermatology
Liv Hospital Ulus
Prof. MD. İlteriş Oğuz
Dermatology
Liv Hospital Ulus
Spec. MD. Ömer Gezdur
Dermatology
Liv Hospital Vadistanbul
Assoc. Prof. MD. Ece Altun
Dermatology
Liv Hospital Vadistanbul
Prof. MD. Sevilay Oğuz Kılıç
Dermatology
Liv Hospital Vadistanbul
Spec. MD. Marziyeh Javadpour
Dermatology
Liv Hospital Vadistanbul
Spec. MD. Meryem Ayşit
Dermatology
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Nadir Göksügür
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Esengül Kaya
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Vedat Ertunç
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Özlem İpek
Dermatology
Liv Hospital Topkapı
Spec. MD. Betül Kızılkan
Dermatology
Liv Hospital Topkapı
Spec. MD. Gizem Gökçedağ Ünsal
Dermatology
Liv Hospital Ankara
Asst. Prof. MD. Caner Demircan
Dermatology
Liv Hospital Ankara
Spec. MD. Aylin Gözübüyükoğulları
Dermatology
Liv Hospital Ankara
Spec. MD. Elçin Akdaş
Dermatology
Liv Hospital Ankara
Spec. MD. Vahid Ahmadi
Dermatology
Liv Hospital Gaziantep
Spec. MD. Hatice Kübra Çakı
Dermatology
Liv Hospital Samsun
Asst. Prof. MD. Gül Şekerlisoy Tatar
Dermatology
Liv Hospital Samsun
Spec. MD. Ayşe İdil Baş
Dermatology
Liv Bona Dea Hospital Bakü
Spec. MD. İRFAN QEHREMANOV
Dermatology
Asst. Prof. MD. A. Deniz Akkaya
Dermatology
MD. Gül Şekerlisoy Tatar
Dermatology
Send us all your questions or requests, and our expert team will assist you.
Basal cell carcinoma (BCC) often appears as a pearly or waxy bump with a raised border and possible central ulceration. Some lesions look like a rough, scaly patch that can be mistaken for eczema or psoriasis. Others are flat, pale, or scar‑like, and may bleed easily. An open sore that persists for weeks or a slowly enlarging pink patch are also warning signs. Early identification of any of these changes, especially after prolonged sun exposure, should prompt a dermatologist visit for evaluation.
The diagnostic pathway for BCC starts with a thorough clinical examination by a board‑certified dermatologist. Dermatoscopy enhances visualization of sub‑surface structures, helping to differentiate BCC from benign lesions. If suspicion remains, a tissue sample is taken via punch, shave, or excisional biopsy, depending on lesion size. The specimen is then reviewed under a microscope by a dermatopathologist to confirm the cancer type and subtype. In high‑risk locations, imaging such as high‑frequency ultrasound or MRI may be used to assess depth of invasion.
Treatment choice depends on lesion size, location, histologic subtype, and patient preference. Surgical excision provides complete removal with clear margins and low recurrence. Mohs micrographic surgery is preferred for facial or cosmetically sensitive sites because it offers the highest cure rate while sparing healthy tissue. Superficial BCCs can be treated with topical agents such as imiquimod or 5‑fluorouracil. Photodynamic therapy is effective for thin lesions and yields good cosmetic outcomes. Radiation therapy is reserved for patients who cannot undergo surgery. Advanced or metastatic BCC may require targeted systemic therapy, such as Hedgehog pathway inhibitors like vismodegib.
After a BCC is removed, Liv Hospital recommends an initial follow‑up visit within 2–4 weeks to assess wound healing and ensure clear margins. Subsequent examinations are scheduled every 3–6 months during the first two years, a period when recurrences are most likely. After that, patients should have an annual full‑body skin examination, especially if they have high‑risk factors or a history of multiple skin cancers. High‑resolution dermoscopy and digital photography are used to document the treated area and detect any new lesions early.
While genetic predisposition cannot be changed, lifestyle modifications significantly lower BCC risk. Apply a broad‑spectrum sunscreen with SPF 30 or higher every day and reapply every two hours when outdoors. Wear UV‑blocking sunglasses, wide‑brimmed hats, and long‑sleeved clothing. Limit exposure during peak UV hours (10 am–4 pm) and avoid indoor tanning devices. Schedule regular dermatologic screenings, especially if you have a personal or family history of skin cancer. These habits not only reduce the chance of new BCC lesions but also promote overall skin health.
Mohs micrographic surgery offers the highest cure rate for BCC because the surgeon removes the tumor layer by layer, examining each under a microscope until clear margins are achieved. It is especially indicated for lesions on the face, ears, eyelids, nose, and other areas where preserving healthy tissue is essential for function and appearance. Mohs is also chosen for recurrent tumors, aggressive histologic subtypes, or lesions with ill‑defined borders. The procedure is performed in a specialized setting, often with same‑day reconstruction.
Basal cell carcinoma is the most common skin cancer and is known for its low metastatic potential. In most cases it remains confined to the skin and underlying tissue. However, if left untreated, it can grow deeply, erode surrounding structures, and cause functional or cosmetic impairment. Very rare cases of metastasis have been reported, usually in long‑standing, large, or neglected tumors. Early detection and treatment are therefore crucial to prevent extensive local damage.
The strongest risk factor for BCC is cumulative ultraviolet (UV) radiation from sun exposure or tanning beds. Individuals with fair skin, light hair, and blue or green eyes are more susceptible. A personal or family history of skin cancer, especially previous BCCs, increases risk. Immunosuppressed patients—such as organ‑transplant recipients or those with HIV—are also at higher risk. Genetic conditions like Gorlin (basal cell nevus) syndrome predispose individuals to multiple BCCs. Lifestyle and occupational sun exposure, along with age, further contribute to the likelihood of developing BCC.
BlogDermatologyApr 10, 2026Did you know over 10 million people in the U.S. have allergies bad enough for allergy immunotherapy? This t...
BlogDermatologyApr 10, 2026Nearly 1 in 5 people who get a chemical peel face skin irritation or reaction. This makes taking good care ...
BlogDermatologyApr 10, 2026More than 100 million people in the United States deal with allergies every year. Finding good allergy reli...
BlogDermatologyApr 10, 2026A dermatopathologist is a doctor who specializes in skin diseases. They look at tissue samples under a micr...
BlogDermatologyApr 09, 2026We focus on aesthetic dermatology, which aims to improve beauty and health. An aesthetic dermatologist is k...
BlogDermatologyApr 09, 2026Discover the vital role of melanocytes in skin health and protection. Learn about their anatomy, function, ...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 174 42 04